| Current approaches for combination therapy of cancer: the role of immunogenic cell death Z Asadzadeh, E Safarzadeh, S Safaei, A Baradaran, A Mohammadi, ... Cancers 12 (4), 1047, 2020 | 125 | 2020 |
| Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy A Derakhshani, Z Rezaei, H Safarpour, M Sabri, A Mir, MA Sanati, ... Journal of cellular physiology 235 (4), 3142-3156, 2020 | 111 | 2020 |
| PD‐1/PD‐L1‐dependent immune response in colorectal cancer Z Payandeh, S Khalili, MH Somi, M Mard‐Soltani, A Baghbanzadeh, ... Journal of cellular physiology 235 (7-8), 5461-5475, 2020 | 103 | 2020 |
| microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities Z Asadzadeh, B Mansoori, A Mohammadi, M Aghajani, ... Journal of cellular physiology 234 (7), 10002-10017, 2019 | 97 | 2019 |
| Immune checkpoints and CAR-T cells: the pioneers in future cancer therapies? N Hosseinkhani, A Derakhshani, O Kooshkaki, M Abdoli Shadbad, ... International Journal of Molecular Sciences 21 (21), 8305, 2020 | 84 | 2020 |
| Recent developments of RNA-based vaccines in cancer immunotherapy E Faghfuri, F Pourfarzi, AH Faghfouri, M Abdoli Shadbad, ... Expert opinion on biological therapy 21 (2), 201-218, 2021 | 76 | 2021 |
| The potential role of miR‐29 in health and cancer diagnosis, prognosis, and therapy M Alizadeh, A Safarzadeh, F Beyranvand, F Ahmadpour, ... Journal of cellular physiology 234 (11), 19280-19297, 2019 | 67 | 2019 |
| The role of CD44 in cancer chemoresistance: A concise review Z Yaghobi, A Movassaghpour, M Talebi, MA Shadbad, ... European journal of pharmacology 903, 174147, 2021 | 62 | 2021 |
| Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness B Mansoori, PHG Duijf, A Mohammadi, S Najafi, E Roshani, ... Expert Opinion on Therapeutic Targets 24 (3), 255-265, 2020 | 49 | 2020 |
| Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes? K Hajiasgharzadeh, S Sadigh‐Eteghad, B Mansoori, A Mokhtarzadeh, ... Journal of cellular physiology 234 (9), 14666-14679, 2019 | 49 | 2019 |
| Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells M Shirmohamadi, E Eghbali, S Najjary, A Mokhtarzadeh, AB Kojabad, ... Journal of cellular physiology 235 (2), 776-789, 2020 | 45 | 2020 |
| Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells N Khosravi, A Mokhtarzadeh, A Baghbanzadeh, K Hajiasgharzadeh, ... Life Sciences 256, 118005, 2020 | 38 | 2020 |
| Small interfering RNA–mediated gene suppression as a therapeutic intervention in hepatocellular carcinoma K Hajiasgharzadeh, MH Somi, D Shanehbandi, A Mokhtarzadeh, ... Journal of Cellular Physiology 234 (4), 3263-3276, 2019 | 38 | 2019 |
| Interleukin-6 impairs chronotropic responsiveness to cholinergic stimulation and decreases heart rate variability in mice K Hajiasgharzadeh, J Mirnajafi-Zadeh, AR Mani European journal of pharmacology 673 (1-3), 70-77, 2011 | 38 | 2011 |
| Photodynamic therapy using zinc phthalocyanine with low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells MA Doustvandi, F Mohammadnejad, B Mansoori, H Tajalli, A Mohammadi, ... Photodiagnosis and photodynamic therapy 28, 88-97, 2019 | 36 | 2019 |
| The dual role of alpha7 nicotinic acetylcholine receptor in inflammation-associated gastrointestinal cancers K Hajiasgharzadeh, MH Somi, S Sadigh-Eteghad, A Mokhtarzadeh, ... Heliyon 6 (3), 2020 | 35 | 2020 |
| The regulatory role of autophagy-related miRNAs in lung cancer drug resistance M Shahverdi, K Hajiasgharzadeh, AD Sorkhabi, M Jafarlou, M Shojaee, ... Biomedicine & Pharmacotherapy 148, 112735, 2022 | 31 | 2022 |
| Cholinergic anti-inflammatory pathway and the liver K Hajiasgharzadeh, B Baradaran Advanced Pharmaceutical Bulletin 7 (4), 507, 2017 | 31 | 2017 |
| Molecular pathways in the development of HPV-induced cervical cancer FR Bonab, A Baghbanzadeh, M Ghaseminia, N Bolandi, A Mokhtarzadeh, ... EXCLI journal 20, 320, 2021 | 30 | 2021 |
| CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel M Aghajani, A Mokhtarzadeh, L Aghebati-Maleki, B Mansoori, ... Molecular biology reports 47, 3691-3703, 2020 | 27 | 2020 |
behzad baradaranImmunology Research Center, Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
